Home > Offer to Sell > Pharmaceuticals and Biochemicals > Dermatological agents > Bacitracin

Bacitracin

Inquiry
  Post Date: Jun 15,2015
  Expiry Date: Jun 14,2016
  Detailed Description: Cas No. :1405-87-4 Appearance
White to pale powder
Complies

  CAS Registry Number:

1405-87-4
  Synonyms: ;Agfivin;Altracin;Ayfivin;Baciquent;Citracin;Penitracin;Topitracin;Zutracin;cyclo[N~6~-(N-{[2-(1-amino-2-methylbutyl)-4,5-dihydro-1,3-thiazol-4-yl]carbonyl}leucyl-alpha-glutamylisoleucyl)-N~2~-asparaginyllysylornithylisoleucylphenylalanylhistidyl-alpha-aspartyl];(4R)-4-[[(2S)-2-[[2-[(1S)-1-amino-2-methyl-butyl]4,5-dihydrothiazole-5-carbonyl]amino]-4-methyl-pentanoyl]amino]-5-[[(1S)-1-[[(3S,6R,9S,12R,15S,18R,21S)-3-(2-amino-2-oxo-ethyl)-18-(3-aminopropyl)-12-benzyl-6-(carboxymethyl)-9-(3H-imidazol-4-ylmethyl)-2,5,8,11,14,17,20-heptaoxo-15-sec-butyl-1,4,7,10,13,16,19-heptazacyclopentacos-21-yl]carbamoyl]-2-methyl-butyl]amino]-5-oxo-pentanoic acid;ai3-50147-x;
  Molecular Formula: C66H103N17O16S
  Molecular Weight: 1422.6933
  Molecular Structure: 1405-87-4 Bacitracin
  Safety Description: S24/25:;

  Company: Lanospharma Laboratories Co.,Ltd     [ China ]        
  Contact: Peter Wen
  Tel: +86-151 8282 8191
  Fax: +86-23-63245915
  Email: sales@lanospharma.com
Disclaimer statement:The information and data included above have been realized by the enterprises and compiled by the staff, and are subject to change without notice to you. The Chemnet makes no warranties or representations whatsoever regarding the facticity, accuracy and validity of such information and data. In order to ensure your interest, we suggest you chose the products posted by our gold suppliers or VIP members.